NCT01860729View on ClinicalTrials.gov

A Study of the Safety and Efficacy of Anacetrapib (MK-0859) Among Participants With Hypercholesterolemia When Added to Ongoing Statin Therapy (MK-0859-022)

PHASE3CompletedINTERVENTIONAL
Enrollment

589

Participants

Timeline

Start Date

May 13, 2013

Primary Completion Date

May 29, 2015

Study Completion Date

August 20, 2015

Conditions
Hypercholesterolemia
Interventions
DRUG

Anacetrapib

DRUG

Placebo

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT01860729 - A Study of the Safety and Efficacy of Anacetrapib (MK-0859) Among Participants With Hypercholesterolemia When Added to Ongoing Statin Therapy (MK-0859-022) | Biotech Hunter | Biotech Hunter